Immune Responses From a New Universal Influenza Vaccine

In this podcast, Florian Krammer, PhD, discusses his team's proof-of-principle trial for a new universal influenza vaccine, as well as how close we are to a universal influenza vaccine.

References:

• Bernstein DI, Guptill J, Naficy A, et al. Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial. Lancet Infect Dis. 2020;20(1):80-91. https://doi.org/10.1016/s1473-3099(19)30393-7. 
• Universal Influenza Vaccine Research. National Institute of Allergy and Infectious Disease. Reviewed September 5, 2019. https://www.niaid.nih.gov/diseases-conditions/universal-influenza-vaccine-research. Accessed January 10, 2020.

Florian Krammer, PhD, is a professor in the Department of Microbiology at the Icahn School of Medicine at Mount Sinai in New York, New York.